Zhengming Du
About Zhengming Du
Zhengming Du is the SVP, Head of CMC at BeiGene in Suzhou, Jiangsu, China, with over 20 years of experience in drug discovery and development.
Current Position at BeiGene
Zhengming Du serves as Senior Vice President (SVP) and Head of Chemistry, Manufacturing, and Controls (CMC) at BeiGene, based in Suzhou, Jiangsu, China. In this role, he is responsible for establishing and maintaining the CMC group, setting strategies, priorities, goals, and objectives for chemical production. He works closely with regulatory functions to manage and provide CMC documentation to support Investigational New Drug (IND) and New Drug Application (NDA) filings.
Previous Experience at Roche Pharmaceuticals
Zhengming Du worked at Roche Pharmaceuticals as Director and Head of Process Research and Synthesis from 2012 to 2015. During his three-year tenure, he was involved in leading process research and synthesis projects, focusing on inventing and optimizing scalable and robust chemical processes for preclinical and clinical studies.
Tenure at Novartis
From 1995 to 2012, Zhengming Du was a Fellow at Novartis, where he accumulated 17 years of experience in drug discovery and development. His work included lead selection and identification, optimization of in vitro and in vivo properties, and structure-based drug design and synthesis.
Educational Background in Organic Chemistry
Zhengming Du earned his Doctor of Philosophy (Ph.D.) in Organic Chemistry from Clark University, studying from 1993 to 1996. Prior to that, he obtained a Bachelor of Science (BSc) in Organic Chemistry from Nanjing University, where he studied from 1978 to 1982.
Expertise in CMC and GMP
Zhengming Du has over 20 years of international industry and academic experience in drug discovery and development. He specializes in inventing and optimizing scalable and robust chemical processes and has extensive experience managing collaborations and outsourcing activities with Contract Research Organizations (CRO) and Contract Manufacturing Organizations (CMO) for pharmaceutical projects. He is skilled in green chemistry, Good Manufacturing Practice (GMP), and API quality control and polymorph process.